Conditioning Factors for High Cardiovascular Risk in Patients with Cushing Syndrome-Reference-Cited by-同舟云学术

Conditioning Factors for High Cardiovascular Risk in Patients with Cushing Syndrome

Published:2015-07 Issue:7 Volume:21 Page:734-742
ISSN:1530-891X
Container-title:Endocrine Practice
language:en
Short-container-title:Endocrine Practice

Author:

Boero Laura,Manavela Marcos,Botta Eliana,Mallea-Gil MariaSusana,Katz Débora,Meroño Tomás,Tetzlaff Walter,Martin Maximiliano,Rosso Leonardo Gómez,Danilowicz Karina,Brites Fernando

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism

Link

http://aace.metapress.com/index/X156163MH249808R.pdf

Reference37 articles.

1. Morbidity and mortality in Cushing's disease: an epidemiological approach;Etxabe;Clin Endocrinol (Oxf),1994

2. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people;Schramm;Circulation,2008

3. Impairment of flow-mediated vasodilatation of brachial artery in patients with Cushing's Syndrome;Baykan;Endocrine,2007

4. Endothelial dysfunction associated with hypercortisolism is reversible in Cushing's syndrome;Akaza;Endocr J,2010

5. Adipokines and cardiovascular risk in Cushing's syndrome;Valassi;Neuroendocrinology,2012

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The patient’s sex determines the hemodynamic profile in patients with Cushing disease;Frontiers in Endocrinology;2023-10-11

2. Emerging functions of adipokines in linking the development of obesity and cardiovascular diseases;Molecular Biology Reports;2020-09-04

3. Should Cushing's Syndrome be Considered as a Disease with High Cardiovascular Risk in Relevant Guidelines?;Current Vascular Pharmacology;2019-12-18

4. Autonomous hypercortisolism: definition and clinical implications;Minerva Endocrinologica;2018-12

5. Primary aldosteronism is associated with decreased low-density and high-density lipoprotein particle concentrations and increased GlycA, a pro-inflammatory glycoprotein biomarker;Clinical Endocrinology;2018-11-20